What is a characteristic of the long-term effects of first-generation antipsychotics?

The development of tardive dyskinesia is indeed a recognized characteristic of the long-term effects of first-generation antipsychotics. Tardive dyskinesia is a potentially irreversible condition characterized by involuntary muscle movements, which may affect the face, tongue, and limbs. This side effect is a significant concern for clinicians prescribing first-generation antipsychotics, as it can emerge after prolonged use of these medications. This highlights the importance of ongoing monitoring and management strategies for individuals who are prescribed these drugs for conditions such as schizophrenia or other severe mental health disorders.

In contrast, the other options do not accurately reflect the realities of using first-generation antipsychotics over an extended period. Rapid recovery from symptoms may occur in the short term for some patients but is not characteristic of long-term use. Similarly, these medications primarily manage symptoms rather than reverse underlying mental health disorders. Finally, an increase in overall mental health is not a typical long-term outcome of the treatment; rather, some patients may experience a reduction in quality of life due to side effects, including tardive dyskinesia and other extrapyramidal symptoms.